vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Zscaler, Inc. (ZS). Click either name above to swap in a different company.
Zscaler, Inc. is the larger business by last-quarter revenue ($788.1M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -1.5%, a 8.3% gap on every dollar of revenue. On growth, Zscaler, Inc. posted the faster year-over-year revenue change (25.5% vs -1.7%). Over the past eight quarters, Zscaler, Inc.'s revenue compounded faster (22.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Zscaler, Inc. is an American cloud security company based in San Jose, California. The company offers cloud-based services to protect enterprise networks and data.
MD vs ZS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $788.1M |
| Net Profit | $33.7M | $-11.6M |
| Gross Margin | — | 76.6% |
| Operating Margin | 9.9% | -4.6% |
| Net Margin | 6.8% | -1.5% |
| Revenue YoY | -1.7% | 25.5% |
| Net Profit YoY | 10.5% | 3.6% |
| EPS (diluted) | $0.40 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $788.1M | ||
| Q3 25 | $492.9M | $719.2M | ||
| Q2 25 | $468.8M | $678.0M | ||
| Q1 25 | $458.4M | $647.9M | ||
| Q4 24 | $502.4M | $628.0M | ||
| Q3 24 | $511.2M | $592.9M | ||
| Q2 24 | $504.3M | $553.2M | ||
| Q1 24 | $495.1M | $525.0M |
| Q4 25 | $33.7M | $-11.6M | ||
| Q3 25 | $71.7M | $-17.6M | ||
| Q2 25 | $39.3M | $-4.1M | ||
| Q1 25 | $20.7M | $-7.7M | ||
| Q4 24 | $30.5M | $-12.1M | ||
| Q3 24 | $19.4M | $-14.9M | ||
| Q2 24 | $-153.0M | $19.1M | ||
| Q1 24 | $4.0M | $-28.5M |
| Q4 25 | — | 76.6% | ||
| Q3 25 | — | 76.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 77.5% | ||
| Q3 24 | — | 78.0% | ||
| Q2 24 | — | 78.6% | ||
| Q1 24 | — | 77.7% |
| Q4 25 | 9.9% | -4.6% | ||
| Q3 25 | 13.8% | -4.5% | ||
| Q2 25 | 12.8% | -3.7% | ||
| Q1 25 | 7.0% | -6.2% | ||
| Q4 24 | 7.8% | -4.9% | ||
| Q3 24 | 6.6% | -4.5% | ||
| Q2 24 | -31.3% | -0.5% | ||
| Q1 24 | 3.2% | -8.7% |
| Q4 25 | 6.8% | -1.5% | ||
| Q3 25 | 14.5% | -2.4% | ||
| Q2 25 | 8.4% | -0.6% | ||
| Q1 25 | 4.5% | -1.2% | ||
| Q4 24 | 6.1% | -1.9% | ||
| Q3 24 | 3.8% | -2.5% | ||
| Q2 24 | -30.3% | 3.5% | ||
| Q1 24 | 0.8% | -5.4% |
| Q4 25 | $0.40 | $-0.07 | ||
| Q3 25 | $0.84 | $-0.11 | ||
| Q2 25 | $0.46 | $-0.03 | ||
| Q1 25 | $0.24 | $-0.05 | ||
| Q4 24 | $0.37 | $-0.08 | ||
| Q3 24 | $0.23 | $-0.09 | ||
| Q2 24 | $-1.84 | $0.12 | ||
| Q1 24 | $0.05 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $1.3B |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $2.0B |
| Total Assets | $2.2B | $6.5B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $1.3B | ||
| Q3 25 | $340.1M | $2.4B | ||
| Q2 25 | $224.7M | $2.0B | ||
| Q1 25 | $99.0M | $1.8B | ||
| Q4 24 | $229.9M | $1.6B | ||
| Q3 24 | $103.8M | $1.4B | ||
| Q2 24 | $19.4M | $1.3B | ||
| Q1 24 | $8.0M | $1.4B |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | $1.1B | ||
| Q1 25 | $590.5M | $1.1B | ||
| Q4 24 | $597.1M | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $865.9M | $2.0B | ||
| Q3 25 | $890.7M | $1.8B | ||
| Q2 25 | $833.8M | $1.8B | ||
| Q1 25 | $789.2M | $1.6B | ||
| Q4 24 | $764.9M | $1.4B | ||
| Q3 24 | $732.5M | $1.3B | ||
| Q2 24 | $706.5M | $1.1B | ||
| Q1 24 | $856.2M | $958.9M |
| Q4 25 | $2.2B | $6.5B | ||
| Q3 25 | $2.2B | $6.4B | ||
| Q2 25 | $2.1B | $5.3B | ||
| Q1 25 | $2.0B | $5.0B | ||
| Q4 24 | $2.2B | $4.7B | ||
| Q3 24 | $2.1B | $4.7B | ||
| Q2 24 | $2.0B | $4.2B | ||
| Q1 24 | $2.2B | $3.9B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | 0.64× | ||
| Q1 25 | 0.75× | 0.71× | ||
| Q4 24 | 0.78× | 0.80× | ||
| Q3 24 | — | 0.90× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 1.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $448.3M |
| Free Cash FlowOCF − Capex | — | $431.0M |
| FCF MarginFCF / Revenue | — | 54.7% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $924.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $448.3M | ||
| Q3 25 | $137.3M | $250.6M | ||
| Q2 25 | $137.2M | $211.1M | ||
| Q1 25 | $-117.5M | $179.4M | ||
| Q4 24 | $133.0M | $331.3M | ||
| Q3 24 | $91.8M | $203.6M | ||
| Q2 24 | $107.0M | $173.4M | ||
| Q1 24 | $-125.2M | $142.1M |
| Q4 25 | — | $431.0M | ||
| Q3 25 | — | $190.6M | ||
| Q2 25 | — | $138.9M | ||
| Q1 25 | — | $164.4M | ||
| Q4 24 | — | $314.3M | ||
| Q3 24 | — | $154.2M | ||
| Q2 24 | — | $137.8M | ||
| Q1 24 | — | $111.2M |
| Q4 25 | — | 54.7% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 20.5% | ||
| Q1 25 | — | 25.4% | ||
| Q4 24 | — | 50.1% | ||
| Q3 24 | — | 26.0% | ||
| Q2 24 | — | 24.9% | ||
| Q1 24 | — | 21.2% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 8.3% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 6.4% | ||
| Q1 24 | — | 5.9% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 9.07× | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
ZS
Segment breakdown not available.
